340 related articles for article (PubMed ID: 23370327)
1. HDAC6 inhibition restores ciliary expression and decreases tumor growth.
Gradilone SA; Radtke BN; Bogert PS; Huang BQ; Gajdos GB; LaRusso NF
Cancer Res; 2013 Apr; 73(7):2259-70. PubMed ID: 23370327
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.
Mansini AP; Lorenzo Pisarello MJ; Thelen KM; Cruz-Reyes M; Peixoto E; Jin S; Howard BN; Trussoni CE; Gajdos GB; LaRusso NF; Perugorria MJ; Banales JM; Gradilone SA
Hepatology; 2018 Aug; 68(2):561-573. PubMed ID: 29406621
[TBL] [Abstract][Full Text] [Related]
3. HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.
Gradilone SA; Habringer S; Masyuk TV; Howard BN; Masyuk AI; Larusso NF
Am J Pathol; 2014 Mar; 184(3):600-8. PubMed ID: 24434010
[TBL] [Abstract][Full Text] [Related]
4. HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.
Peixoto E; Jin S; Thelen K; Biswas A; Richard S; Morleo M; Mansini A; Holtorf S; Carbone F; Pastore N; Ballabio A; Franco B; Gradilone SA
Am J Physiol Gastrointest Liver Physiol; 2020 Jun; 318(6):G1022-G1033. PubMed ID: 32338033
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
Zhang KS; Zhou Q; Wang YF; Liang LJ
Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
[TBL] [Abstract][Full Text] [Related]
8. Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma.
Gradilone SA; Pisarello MJL; LaRusso NF
Curr Drug Targets; 2017; 18(8):958-963. PubMed ID: 25706257
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment.
Yu Y; Liao M; Liu R; Chen J; Feng H; Fu Z
World J Surg Oncol; 2014 Mar; 12():78. PubMed ID: 24679073
[TBL] [Abstract][Full Text] [Related]
10. Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts.
Assawasuparerk K; Rawangchue T; Phonarknguen R
Asian Pac J Cancer Prev; 2016; 17(4):2151-7. PubMed ID: 27221911
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.
Okabe H; Beppu T; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Jono H; Ueda M; Shinriki S; Ando Y; Baba H
Ann Surg Oncol; 2011 Apr; 18(4):1175-84. PubMed ID: 21042948
[TBL] [Abstract][Full Text] [Related]
12. Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.
Frampton G; Coufal M; Li H; Ramirez J; DeMorrow S
Exp Cell Res; 2010 May; 316(9):1465-78. PubMed ID: 20347808
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
Sriraksa R; Limpaiboon T
Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
Meng F; Yamagiwa Y; Ueno Y; Patel T
J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
[TBL] [Abstract][Full Text] [Related]
16. Leptin enhances cholangiocarcinoma cell growth.
Fava G; Alpini G; Rychlicki C; Saccomanno S; DeMorrow S; Trozzi L; Candelaresi C; Venter J; Di Sario A; Marzioni M; Bearzi I; Glaser S; Alvaro D; Marucci L; Francis H; Svegliati-Baroni G; Benedetti A
Cancer Res; 2008 Aug; 68(16):6752-61. PubMed ID: 18701500
[TBL] [Abstract][Full Text] [Related]
17. Contribution of RIZ1 to regulation of proliferation and migration of a liver fluke-related cholangiocarcinoma cell.
Khaenam P; Niibori A; Okada S; Jearanaikoon P; Araki N; Limpaiboon T
Asian Pac J Cancer Prev; 2012; 13(8):4007-11. PubMed ID: 23098508
[TBL] [Abstract][Full Text] [Related]
18. HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia.
Xiang W; Guo F; Cheng W; Zhang J; Huang J; Wang R; Ma Z; Xu K
Oncol Rep; 2017 Jul; 38(1):229-236. PubMed ID: 28586053
[TBL] [Abstract][Full Text] [Related]
19. Scabraside D Extracted from Holothuria scabra Induces Apoptosis and Inhibits Growth of Human Cholangiocarcinoma Xenografts in Mice.
Assawasuparerk K; Vanichviriyakit R; Chotwiwatthanakun C; Nobsathian S; Rawangchue T; Wittayachumnankul B
Asian Pac J Cancer Prev; 2016; 17(2):511-7. PubMed ID: 26925636
[TBL] [Abstract][Full Text] [Related]
20. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
